Archives
-
Polymer Pen Lithography for 3D SERS Arrays
2026-08-20
The reference study presents polymer pen lithography as a controllable route for constructing three-dimensional gold nanoparticle cluster arrays for surface-enhanced Raman scattering. By combining patterned polyethylenimine scaffolds with electrostatic nanoparticle assembly, the authors achieve strong enhancement, low reported variability, and structural tunability without relying on costly conventional nanolithography.
-
Sulfisomidine: From Clinical Data to Assay Design
2026-08-20
Sulfisomidine, also known as sulfamethin, connects historical exposure data with modern bacterial and hPON1 assay design. This article explains how to use its mechanism, physicochemical properties, and pharmacokinetic observations to improve enzyme kinetics, oxidative stress, and cell-based studies.
-
Gentamycin Sulfate: From Ribosome to Resistance Strategy
2026-08-19
Gentamycin Sulfate is more than a routine selection antibiotic: it is a mechanistic probe for bacterial translation, a stressor for resistance modeling, and a bridge between ribosome biology and clinically relevant Gram-negative susceptibility questions. This article outlines how translational researchers can use it strategically alongside contemporary resistance data.
-
WAY-100635 as a Causal Probe in Pain Research
2026-08-19
WAY-100635 enables precise interrogation of 5-HT1A signaling in pain, affective, and imaging studies. This article presents a causal assay framework that connects serotonin receptor antagonist research with emerging cannabinoid pain biology without overstating the evidence.
-
Palonosetron: From Receptor Selectivity to Translation
2026-08-18
A translational framework for using palonosetron hydrochloride to connect durable 5-HT3 receptor pharmacology with renal transporter liability, antiemetic development, and cancer research strategy.
-
5-Aminolevulinic acid HCl in Cell Assays
2026-08-18
Learn how 5-Aminolevulinic acid HCl (SKU B2070) can be incorporated into reproducible viability, proliferation, cytotoxicity, and heme-pathway experiments. This scenario-based guide covers formulation, controls, storage, interpretation, and vendor-selection criteria while distinguishing product specifications from literature-based biological conclusions.
-
SP2509 and the Translational Logic of LSD1 Targeting
2026-08-17
SP2509 links selective LSD1 antagonism to chromatin remodeling, AML differentiation, apoptosis, and translational assay strategy while defining what can—and cannot—be inferred from broader cancer epigenetics research.
-
L-NMMA acetate for NOS Pathway Studies
2026-08-17
L-NMMA acetate enables controlled, pathway-level suppression of nitric oxide synthase activity in differentiation, inflammation, and disease-model experiments. This workflow-oriented guide shows how to pair N(G)-monomethyl-L-arginine acetate with NO, cGMP, viability, and phenotype assays for more defensible mechanistic conclusions.
-
Cannabidiol and Orofacial Inflammatory Pain
2026-08-16
A 2026 Brain Research Bulletin study shows that cannabidiol (CBD) can reduce both nociceptive and affective abnormalities in inflammatory pain models through coordinated peripheral, central, endocannabinoid, and serotonergic effects. Its multi-model design provides a useful framework for investigating pain-related emotional and cognitive dysfunction, while also highlighting the need for receptor-specific validation and improved translational models.
-
Palonosetron Hydrochloride: Assay Design Guide
2026-08-15
Palonosetron hydrochloride is a highly selective 5-HT3 receptor antagonist with distinct receptor and renal transporter assay windows. This guide translates its pharmacology into practical experimental decisions for cancer research, CINV/RINV studies, and OCT2/MATE1 workflows.
-
ARCA capped mRNA synthesis kit: HyperScribe™
2026-08-14
Build translation-ready, modified mRNA in one coordinated workflow using ARCA capping, 5mCTP, ψUTP, DNase treatment, and enzymatic poly(A) tailing. The kit is especially useful when RNA vaccine development, in vitro translation, or RNA interference experiments require consistent cap, nucleotide modification, and tailing steps.
-
Carvedilol Phosphate in IRI Research
2026-08-14
Carvedilol Phosphate is a phosphate salt derivative and non-selective beta blocker used as a research reagent for GPCR and cardiovascular pharmacology research. Its documented physicochemical profile supports controlled formulation studies, while current hepatic ischemia–reperfusion evidence provides biological rationale rather than direct proof of efficacy.
-
Optimized GBA1 mRNA for Gaucher Disease Therapy
2026-08-13
The reference study develops a rationally optimized human GBA1 mRNA platform by modifying untranslated regions, codon usage, and poly(A) tails. The resulting mRNA increased glucocerebrosidase expression, restored lysosomal phenotypes in GBA1-deficient cells, and produced detectable enzyme activity in mouse liver and spleen after lipid-nanoparticle delivery.
-
H5N1 mRNA Vaccine Protects Lactating Dairy Cows
2026-08-13
A hemagglutinin-encoding mRNA–lipid nanoparticle vaccine protected lactating dairy cows from high-dose H5N1 challenge and did not impair health or milk production. The study is notable for demonstrating complete short-term protection and substantial protection months later, even when serum antibody concentrations had become low.
-
Fenofibrate: A PPARα–YAP Assay Framework
2026-08-12
Fenofibrate is a PPARα agonist whose effects extend from lipid metabolism to YAP-dependent liver remodeling. This assay-focused guide explains how to distinguish receptor activation, tissue adaptation, and preclinical anticancer phenotypes.